Novavax
NVAX
#5727
Rank
ยฃ0.97 B
Marketcap
ยฃ5.90
Share price
-3.02%
Change (1 day)
21.46%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2026 (TTM): -ยฃ1.13

According to Novavax's latest financial reports the company's current EPS (TTM) is -ยฃ1.16. In 2025 the company made an earnings per share (EPS) of ยฃ2.09 an increase over its 2024 EPS that were of -ยฃ0.94.

EPS history for Novavax from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ1.13-154.24%
2025ยฃ2.09-322.76%
2024-ยฃ0.94
2022-ยฃ6.34-64.36%
2021-ยฃ17.79243%
2020-ยฃ5.1919.75%
2019-ยฃ4.33-43.86%
2018-ยฃ7.71-19.84%
2017-ยฃ9.62-38.83%
2016-ยฃ15.7374.58%
2015-ยฃ9.0163.89%
2014-ยฃ5.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
ยฃ4.01-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.54-146.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ5.44-568.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ2.20-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-ยฃ2.01 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ3.32 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ1.54-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-ยฃ0.34-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ1.03-11.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-ยฃ3.85 231.58%๐Ÿ‡บ๐Ÿ‡ธ USA